Navigation Links
REOLYSIN in Medical News

Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells

...id neurosurgeon John S. Yu, M.D., director of Surgical Neuro-oncology at Cedars-Sinais Department of Neurosurgery. Yu is principal investigator of the reolysin clinical trial at Cedars-Sinai. According to the protocol of this open-label Phase I and II trial, patients will receive a single treatment of REO...

Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials

...terim results from a U.K. Phase Ia/Ib combination reolysin and radiation clinical trial for patients with adv...the trial received two intratumoural treatments of reolysin at dosages of 1x108, 1x109, or 1x1010 TCID50 with ...ved either two, four or six intratumoural doses of reolysin at 1x1010 TCID50 with a constant localized radiati...

Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs

... investigators examining various co-therapies with reolysin is providing Oncolytics with the rationale for its...fficer at Oncolytics. "This research suggests that reolysin can be combined with many existing therapies that ...he treatment of cancer patients." Currently, reolysin is being used in Phase I and Phase I/II human clin...
REOLYSIN in Medical Technology

Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial

CALGARY, June 05, 2007 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") announced today positive results from its U.S. Phase I clinical trial examining the systemic administration of REOLYSIN(R) in patients with advanced cancers. The results indicate that REOLYSIN(R) can be delivere...

Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC

...ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...
REOLYSIN in Biological News

Oncolytics Biotech, Inc. announces publication of research

...appears online in the January 1, 2008 issue of Clinical Cancer Research. This exciting Mayo Clinic work supported the initiation of our combination reolysin and cyclophosphamide clinical trial, recently approved by the U.K. health authorities, said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. ...

Dealing deadly cancers a knockout punch

...melanomas. Recent studies also indicate that reolysin works synergistically with standard anti-cancer dr...ther studies completed in the past year have shown reolysin has the ability to prime patients' immune systems ...ond "inflammatory" mechanism that researchers hope reolysin will bring about long-term remissions of once-untr...
REOLYSIN in Biological Technology

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...ed by our investigators, reinforce our belief that reolysin has the potential to significantly improve treatme...ASCO demonstrating that the combination of reolysin and gemcitabine in a U.K. Phase I trial was well t... - Presented a poster at ASCO that indicated reolysin was well tolerated and demonstrated anti-t...

Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)

...y completed an initial 100-litre production run of reolysin under cGMP conditions. This run is anticipated to ...s, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely comp...

Oncolytics Biotech(R) Inc. Completes Lyophilization Process for REOLYSIN(R)

...the lyophilization process, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...

Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

...ating delivery of REOLYSIN, and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown risks and uncertainties,... and resources to pursue research and development projects, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studie...

Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial

...e Phase II component of a Phase I/II U.K. trial of reolysin combined with paclitaxel/carboplatin for patients ... Phase III pivotal program now being developed for reolysin in combination with carboplatin/paclitaxel for hea...atory Phase II trial using the same combination of reolysin and carboplatin/paclitaxel for patients with head ...

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting

...ntation, entitled "A Phase II Study of Intravenous reolysin (Wild-type Reovirus) in the Treatment of Patients ...es in whom the IDD group are investigating various reolysin regimens," said Dr. Frank Giles, Director, IDD, an... Deputy Director, CTRC at UTHSCSA. Additional reolysin results presented Two additional poster prese...

Oncolytics Biotech(R) Inc.'s Research Collaborators to Present Data on REOLYSIN(R) Clinical Trials at ASCO Conference

...d today that data from three clinical trials using reolysin are scheduled to be presented at the 2009 American...he ASCO website today at www.asco.org . reolysin poster presentations - Dr. Monica Mita and ... I Study of the Combination of Intravenous reolysin (REO) and Gemcitabine (GEM) in Patients (pts) ...

Oncolytics(R) Biotech Inc. Completes Patient Enrolment in U.S. Phase 2 Sarcoma Study

... antitumour activity of intravenous, multiple dose reolysin in patients with bone and soft tissue sarcomas metastatic to the lung. reolysin is delivered intravenously to patients at a dose o...al and the Company's belief as to the potential of reolysin as a cancer therapeutic, involve known and unknown...

Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results

...l benefit in the majority of patients treated with reolysin in combination with chemotherapy or radiation, pav... results from a U.K. Phase I/II combination reolysin and paclitaxel/carboplatin trial for patients with...Announced positive results from a U.K. combination reolysin and docetaxel trial for patients with a var...

Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting

... results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of reolysin as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of phar...
Other Tags
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional ... all of the models at LunaDress.co.uk come with big discounts, up ... wedding veil can turn out to be a most exciting memory ... can always bring surprise to a wedding. On the updated fashion ... choose veils for a big day . , Going out with ...
(Date:12/25/2014)... (HealthDay News) -- Among early stage breast cancer patients ... of one percent will eventually develop leukemia as a ... The finding comes from a review of more than ... and it suggests that the risk for developing treatment-related ... previously thought. "The frequency of bone marrow cancers ...
(Date:12/25/2014)... 25, 2014 “ SmileStix ” was featured ... the latest and coolest mobile applications on the iOS, Android, ... host of NewsWatch, conducted the app review and shared with ... personal stickers. , The old saying goes, “A picture says ... words that can describe a single image, because each picture ...
(Date:12/25/2014)... Parker & Sons, Inc. an industry leader ... quality regarding heating, cooling and plumbing services in the ... the “Queen of Clean” for impressive contractor services in ... over the years for providing outstanding quality customer service ... services for both homeowners and businesses. Linda Cobb, known ...
(Date:12/24/2014)... TX (PRWEB) December 24, 2014 Connie ... specialist and functional medicine advocate with 30 years of ... trial to evaluate the health benefits of dietary detoxification. ... with new participants following excellent results from test patients ... When asked to explain her interest in conducting the ...
Breaking Medicine News(10 mins):Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... New York College, and one of the most prolific ... signals that are transmitted from Smartphones to third party ... Smartphones and has one of the earliest known patents ... its usage in the military, child care, elder care ...
(Date:11/21/2014)... , Nov. 20, 2014   Atmel® Corporation ... microcontroller (MCU) and touch technology solutions, today launched the ... with the widest V cc range from ... accuracy and faster I 2 C bus communication speeds, ... EEPROM memory making them ideal for consumer, industrial, computer, ...
(Date:11/18/2014)... The Parenteral Drug Association (PDA) today confirmed that ... and at least seven more will participate in the upcoming ... Hotel in Washington D.C. , Dec. 2-4. ... support from the regulatory agencies in the United ... our effort to help advance the use of metrics in ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
Other Contents